Found: 64
Select item for more details and to access through your institution.
Prospects of Synergy: Local Interventions and CAR T Cell Therapy in Solid Tumors.
- Published in:
- BioDrugs, 2024, v. 38, n. 5, p. 611, doi. 10.1007/s40259-024-00669-y
- By:
- Publication type:
- Article
A fluorescence in situ hybridization-based screen allows rapid detection of adverse cytogenetic alterations in patients with acute myeloid leukemia.
- Published in:
- Genes, Chromosomes & Cancer, 2017, v. 56, n. 8, p. 632, doi. 10.1002/gcc.22466
- By:
- Publication type:
- Article
Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia.
- Published in:
- Infection, 2023, v. 51, n. 1, p. 231, doi. 10.1007/s15010-022-01909-5
- By:
- Publication type:
- Article
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy: Roadmap from an ELN‐DAVID expert panel.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 12, p. 1847, doi. 10.1002/ajh.27087
- By:
- Publication type:
- Article
The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1699, doi. 10.1002/ajh.27056
- By:
- Publication type:
- Article
Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity.
- Published in:
- Bone Marrow Research, 2014, p. 1, doi. 10.1155/2014/541345
- By:
- Publication type:
- Article
Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria.
- Published in:
- Cancer Imaging, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s40644-023-00566-7
- By:
- Publication type:
- Article
Ten things the hematologist wants you to know about CAR-T cells.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Radiologic and Pathologic Features of a Posttransplantation Primary Central Nervous System Lymphoma Demonstrating Epstein-Barr Virus–Positive Hodgkin Lymphoma.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, n. 8, p. 535
- By:
- Publication type:
- Article
CAR T in DLBCL -- "Came to Stay".
- Published in:
- Turkish Journal of Hematology, 2021, v. 38, p. 35
- By:
- Publication type:
- Article
An update of novel identified cytogenetic and molecular biomarkers in the laboratory diagnosis of hematological neoplasia.
- Published in:
- Journal of Laboratory Medicine / Laboratoriums Medizin, 2015, v. 39, n. 5, p. 325, doi. 10.1515/labmed-2015-0047
- By:
- Publication type:
- Article
Management of Patients Undergoing CAR-T Cell Therapy in Germany.
- Published in:
- Oncology Research & Treatment, 2024, v. 47, n. 3, p. 65, doi. 10.1159/000536201
- By:
- Publication type:
- Article
Abundant glutamic acid decarboxylase (GAD)-reactive B cells in gad-antibody-associated neurological disorders.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Wir stehen vor einer Dekade der personalisierten T-Zell basierten Therapiestrategien.
- Published in:
- Kompass Onkologie, 2021, v. 8, n. 3, p. 113, doi. 10.1159/000519040
- By:
- Publication type:
- Article
Schwere Candida-glabrata-Pankolitis und letale Aspergillus-fumigatus-Lungeninfektion vor dem Hintergrund einer Knochenmarkaplasie nach CD19-spezifischer CAR T-Zell-Therapie – ein Fallbericht.
- Published in:
- Kompass Onkologie, 2021, v. 8, n. 3, p. 159, doi. 10.1159/000518824
- By:
- Publication type:
- Article
Integrated multiomic approach for identification of novel immunotherapeutic targets in AML.
- Published in:
- Biomarker Research, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40364-022-00390-4
- By:
- Publication type:
- Article
Integrated multiomic approach for identification of novel immunotherapeutic targets in AML.
- Published in:
- Biomarker Research, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40364-022-00390-4
- By:
- Publication type:
- Article
The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01465-x
- By:
- Publication type:
- Article
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01379-0
- By:
- Publication type:
- Article
SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01163-6
- By:
- Publication type:
- Article
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1361, doi. 10.1007/s00259-023-06554-0
- By:
- Publication type:
- Article
Novel Vpx virus-like particles to improve cytarabine treatment response against acute myeloid leukemia.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01425-w
- By:
- Publication type:
- Article
Sarcoid-Like Reaction in Non-Hodgkin's Lymphoma—A Diagnostic Challenge for Deauville Scoring on 18 F-FDG PET/CT Imaging.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 6, p. 1009, doi. 10.3390/diagnostics11061009
- By:
- Publication type:
- Article
Activating FLT3 Mutants Show Distinct Gain-of-Function Phenotypes In Vitro and a Characteristic Signaling Pathway Profile Associated with Prognosis in Acute Myeloid Leukemia.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0089560
- By:
- Publication type:
- Article
CD86 and IL-12p70 Are Key Players for T Helper 1 Polarization and Natural Killer Cell Activation by Toll-Like Receptor-Induced Dendritic Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0044266
- By:
- Publication type:
- Article
Immunotherapy in Tumors.
- Published in:
- Deutsches Ärzteblatt International, 2015, v. 112, n. 48, p. 809, doi. 10.3238/arztebl.2015.0809
- By:
- Publication type:
- Article
Chimeric Antigen Receptor–Modified T Cells and T Cell–Engaging Bispecific Antibodies: Different Tools for the Same Job.
- Published in:
- Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 218, doi. 10.1007/s11899-021-00628-2
- By:
- Publication type:
- Article
The BiTE (bispecific T-cell engager) platform: Development and future potential of a targeted immuno-oncology therapy across tumor types.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 3, p. 480, doi. 10.1111/bjh.14901
- By:
- Publication type:
- Article
Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Structures of the human and Drosophila 80S ribosome.
- Published in:
- Nature, 2013, v. 497, n. 7447, p. 80, doi. 10.1038/nature12104
- By:
- Publication type:
- Article
PET/CT imaging for tumour response assessment to immunotherapy: current status and future directions.
- Published in:
- European Radiology Experimental, 2020, v. 4, n. 1, p. N.PAG, doi. 10.1186/s41747-020-00190-1
- By:
- Publication type:
- Article
Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32772-5
- By:
- Publication type:
- Article
STING agonism turns human T cells into interferon‐producing cells but impedes their functionality.
- Published in:
- EMBO Reports, 2023, v. 24, n. 3, p. 1, doi. 10.15252/embr.202255536
- By:
- Publication type:
- Article
Functional connectivity MRI provides an imaging correlate for chimeric antigen receptor T-cell-associated neurotoxicity.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad135
- By:
- Publication type:
- Article
First‐in‐human study of JNJ‐67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 3, p. 1, doi. 10.1111/cts.13742
- By:
- Publication type:
- Article
Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 5, p. 1406, doi. 10.1007/s00259-022-06075-2
- By:
- Publication type:
- Article
Transformation of diffuse large B cell lymphoma into dendritic sarcoma under CAR T cell therapy detected on 18F-FDG PET/CT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 5, p. 1692, doi. 10.1007/s00259-020-05000-9
- By:
- Publication type:
- Article
Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03688-4
- By:
- Publication type:
- Article
Correction to: CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2499, doi. 10.1007/s00262-023-03439-x
- By:
- Publication type:
- Article
Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune responses against viral and tumor-associated antigens.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1705, doi. 10.1007/s00262-021-03109-w
- By:
- Publication type:
- Article
A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1353, doi. 10.1007/s00262-020-02552-5
- By:
- Publication type:
- Article
RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1505, doi. 10.1007/s00262-015-1755-8
- By:
- Publication type:
- Article
New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 10, p. 1093, doi. 10.1007/s00262-014-1600-5
- By:
- Publication type:
- Article
Lymphoma tumor burden before chimeric antigen receptor T-Cell treatment: RECIL vs. Lugano vs. metabolic tumor assessment.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.974029
- By:
- Publication type:
- Article
Presentation of Epstein-Barr virus latency antigens to CD8.
- Published in:
- European Journal of Immunology, 1999, v. 29, n. 12, p. 3995, doi. 10.1002/(SICI)1521-4141(199912)29:12<3995::AID-IMMU3995>3.0.CO;2-E
- By:
- Publication type:
- Article
CAR T-Cells for CNS Lymphoma: Driving into New Terrain?
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2503, doi. 10.3390/cancers13102503
- By:
- Publication type:
- Article
Chimeric Antigen Receptor T Cells: A Race to Revolutionize Cancer Therapy.
- Published in:
- Transfusion Medicine & Hemotherapy, 2019, v. 46, n. 1, p. 15, doi. 10.1159/000496870
- By:
- Publication type:
- Article